Deep molecular response in chronic myeloid leukemia

被引：0
|
作者：
N C P Cross
A Hochhaus
机构：
[1] Faculty of Medicine,Abteilung Hämatologie/Onkologie
[2] University of Southampton,undefined
[3] National Genetics Reference Laboratory (Wessex),undefined
[4] Klinik für Innere Medizin II,undefined
[5] Universitätsklinikum Jena,undefined
来源：
Leukemia | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1632 / 1632
相关论文
共 50 条
  • [21] Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients
    Estrada, Natalia
    Xicoy, Blanca
    Beier, Fabian
    Garcia, Olga
    Morales, Cristian
    Boque, Concepcion
    Saguees, Miguel
    Ferreira, Monica S. Ventura
    Vallansot, Rolando
    Marce, Silvia
    Cabezon, Marta
    Brummendorf, Tim H.
    Zamora, Lurdes
    [J]. HEMASPHERE, 2021, 5 (12):
  • [22] Prediction of deep molecular response in chronic myeloid leukemia using supervised machine learning models
    Zad, Zahra
    Bonecker, Simone
    Wang, Taiyao
    Zalcberg, Ilana
    Stelzer, Gustavo T.
    Sabioni, Bruna
    Gutiyama, Luciana Mayumi
    Fleck, Julia L.
    Paschalidis, Ioannis Ch.
    [J]. LEUKEMIA RESEARCH, 2024, 141
  • [23] Is it time to reconsider molecular response milestones in chronic myeloid leukemia?
    Walia, Anushka
    Prasad, Vinay
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (04) : 562 - 563
  • [24] Assessment of Early Molecular Response in Tunisian Chronic Myeloid Leukemia
    Frikha, Rim
    Elloumi, Moez
    Kamoun, Hassen
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S230 - S230
  • [25] Factors Affecting Early Molecular Response in Chronic Myeloid Leukemia
    Chikkodi, Santosh V.
    Malhotra, Pankaj
    Naseem, Shano
    Khadwal, Alka
    Prakash, Gaurav
    Sahu, Kamal Kant
    Kumari, Savita
    Suri, Vikas
    Varma, Neelam
    Varma, Subhash
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S114 - S119
  • [26] NEW TOOL FOR MONITORING MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA
    Badar, T.
    Kantarjian, H.
    Jabbour, E.
    Borthakur, G.
    Daver, N.
    Huang, X.
    Alvarez, B.
    Austermiller, B.
    Morrison, T.
    Cortes, J.
    [J]. HAEMATOLOGICA, 2015, 100 : 443 - 443
  • [27] DEFINITIONS AND STANDARDISATION OF 'COMPLETE' MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA
    White, H.
    Mueller, M.
    Colomer, D.
    Daraio, F.
    Dulucq, S.
    Ehrencrona, H.
    Foroni, L.
    Iaccobucci, I.
    Izzo, B.
    Lange, T.
    Lion, T.
    Machova, K.
    Pallisgaard, N.
    Sacha, T.
    Talmaci, R.
    Barbany, G.
    Saglio, G.
    Piccolo, C.
    Giles, F.
    Hochhaus, A.
    Cross, N.
    [J]. HAEMATOLOGICA, 2012, 97 : 308 - 309
  • [28] Molecular response to imatinib in patients with chronic myeloid leukemia in Tanzania
    Nasser, Ahlam
    Hussein, Ally
    Chamba, Clara
    Yonazi, Mbonea
    Mushi, Rosemary
    Schuh, Anna
    Luzzatto, Lucio
    [J]. BLOOD ADVANCES, 2021, 5 (05) : 1403 - 1411
  • [29] New tool for monitoring molecular response in chronic myeloid leukemia
    Badar, Talha
    Luthra, Rajyalakshmi
    Kantarjian, Hagop M.
    Jabbour, Elias
    Borthakur, Gautam
    Daver, Naval Guastad
    Huang, Xuelin
    Singh, Rajesh
    Alvarez, Brittany
    Morrison, Tom
    Cortes, Jorge E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia
    Jong-Ho Park
    Young Min Woo
    Emilia Moonkyung Youm
    Nada Hamad
    Hong-Hee Won
    Kazuhito Naka
    Eun-Ju Park
    June-Hee Park
    Hee-Jin Kim
    Sun-Hee Kim
    Hyeoung-Joon Kim
    Jae Sook Ahn
    Sang Kyun Sohn
    Joon Ho Moon
    Chul Won Jung
    Silvia Park
    Jeffrey H. Lipton
    Shinya Kimura
    Jong-Won Kim
    Dennis (Dong Hwan) Kim
    [J]. Leukemia, 2019, 33 : 1439 - 1450
12345